Ayers Jonathan W's Form 4 filing
IDEXX Laboratories Inc (IDXX) · filed Feb 17, 2022
- Accession no.
- 0001567619-22-004965
- Filed
- Feb 17, 2022
- Trade date
- Feb 11-15, 2022
- Filing delay
- 6 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $127.4K. It was filed 6 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ayers Jonathan WCIK 0001184149 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 11, 2022 | Common Stock | GGiftDisposed | −8,000 | $0.00 | $0 | 629,740 | Direct | |
| Feb 15, 2022 | Common Stock | SSaleDisposed | −250 | $509.70 | −$127,425 | 629,490 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.